EEG investigation of gait and balance in Parkinson*s disease using immersive virtual reality

EEG investigation of gait and balance in Parkinson*s disease using immersive virtual reality - EEG investigation of gait and balance using VR

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40694

Enrollment

Registered

2014-08-25

Start date

2015-02-25

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Idiopathic Parkinson's disease - Age between 45 -70 years - Moderate disease severity (Hoehn-Yahr 2-3)

Exclusion criteria

Exclusion criteria: - Other neurological or psychiatric conditions, including stroke, traumatic brain injury, epilepsy, depression or anxiety disorder - Electronic equipment implanted - Severe visual impairment - Declining to be informed of medically relevant chance findings in the investigation

Design outcomes

Primary

Measure	Time frame
Primary study parameters: - power values of EEG oscillatory activity in different frequency bands - phase relationship of oscillations with external events - phase relationship of oscillations at different frequencies (cross-frequency coupling) - cortical distribution of oscillatory activity	—

Secondary

Measure	Time frame
Secondary study parameters: -Gait-coordination parameters i.e. step length, width, symmetry and frequency, relative phase relationship between arms, legs and trunk movements. Descriptive study parameters: - Clinical characteristics: Unified Parkinsons Disease Rating Scale, - Walking performance: 10 meter walk test; freezing of Gait Questionnaire - Balance performance: Single leg stance test - Activities of Daily Living: Nottingham Extended ADL Index - Quality of life: Short-form-36; Parkinsons Disease Questionnaire-39	—

Measure

Time frame

Secondary study parameters: -Gait-coordination parameters i.e. step length, width, symmetry and frequency, relative phase relationship between arms, legs and trunk movements. Descriptive study parameters: - Clinical characteristics: Unified Parkinson*s Disease Rating Scale, - Walking performance: 10 meter walk test; freezing of Gait Questionnaire - Balance performance: Single leg stance test - Activities of Daily Living: Nottingham Extended ADL Index - Quality of life: Short-form-36; Parkinson*s Disease Questionnaire-39

—

Countries

Netherlands

Outcome results